生殖道沙眼衣原体感染的疾病负担研究进展

doi:10.12183/j.scjpm.2023.1075

[1] Unemo M,Bradshaw CS,Hocking JS,et al.Sexually transmitted infections: Challenges ahead[J].Lancet Infect Dis,2017,17(8):e235-e279.
[2] 中国疾病预防控制中心性病控制中心, 中华医学会皮肤性病学分会性病学组, 中国医师协会皮肤科医师分会性病亚专业委员会.梅毒,淋病和生殖道沙眼衣原体感染诊疗指南(2020年)[J].中华皮肤科杂志,2020,53(3):168-179.
[3] Dombrowski JC.Chlamydia and gonorrhea[J].Ann Intern Med,2021,174(10): 145-160.
[4] Tang W, Mao J, Li KT, et al.Pregnancy and fertility-related adverse outcomes associated with Chlamydia trachomatis infection: A global systematic review and meta-analysis[J]. Sex Transm Infect,2020,96(5):322-329.
[5] Bhuvanendran Pillai A, Mun Wong C, Dalila Inche Zainal Abidin N, et al. Chlamydia infection as a risk factor for cervical cancer: A systematic review and meta-analysis[J]. Iran J Public Health,2022,51(3):508-517.
[6] Dzakah EE, Zhao J, Wang L, et al.Chlamydia trachomatis stimulation enhances HIV-1 susceptibility through the modulation of a member of the macrophage inflammatory proteins[J].J Invest Dermatol,2022,142(5):1338-1348.
[7] 马婉婉,朱玉良,苏斌,等.传染病类疾病负担评价方法研究进展[J].安徽预防医学杂志, 2019,25(5):374-377,385.
[8] Yoon SJ, Go DS, Park H, et al.The Korean national burden of disease study: From evidence to policy[J]. J Korean Med Sci,2019,34(Suppl 1):e89.
[9] World Health Organization.Global progress report on HIV, viral hepatitis and sexually transmitted infections,2021: Accountability for the global health sector strategies 2016-2021: Actions for impact:Web annex 2: Data methods[M].Geneva:World Health Organization, 2021:8.
[10] Low N, Hocking JS, Van Bergen J.The changing landscape of chlamydia control strategies[J].Lancet,2021,398(10309):1386-1388.
[11] Kirby Institute.HIV, viral hepatitis and sexually transmissible infections in Australia:Annual surveillance report 2022[M].Sydney:Kirby Institute,UNSW,2022:5.
[12] Public Health Agency of Canada. Chlamydia,gonorrhea and infectious syphilis in Canada,2019(infographic)[EB/OL].(2022-02-14)[2022-09-12].https://www.canada.ca/en/public-health/services/publications/diseases-conditions/chlamydia-gonorrhea-infectious-syphili-canada-2019.html.
[13] 岳晓丽,龚向东,李婧,等.2015—2019年中国性病监测点生殖道沙眼衣原体感染流行病学特征[J].中华皮肤科杂志,2020,53(8):596-601.
[14] Huai P, Li F, Li Z, et al.Prevalence, risk factors, and medical costs of Chlamydia trachomatis infections in Shandong Province,China: A population-based,cross-sectional study[J].BMC Infect Dis,2018,18(1):534.
[15] Li C, Tang W, Ho HC, et al. Prevalence of chlamydia trachomatis among pregnant women, gynecology clinic attendees,subfertile women in Guangdong, China:A cross-sectional survey[J].Open Forum Infect Dis,2021,8(6):ofab206.
[16] Gerbase A, Stein C, Levison J, et al.Global burden of sexually transmitted diseases (excluding HIV) in the year 2000[M].Geneva:World Health Organization,2000:5.
[17] Davies B, Turner KME, Frolund M, et al.Risk of reproductive complications following chlamydia testing:A population-based retrospective cohort study in Denmark[J].Lancet Infect Dis,2016,16(9):1057-1064.
[18] Den Heijer CDJ, Hoebe CJPA, Driessen JHM, et al.Chlamydia trachomatis and the risk of pelvic inflammatory disease, ectopic pregnancy, and female infertility:A retrospective cohort study among primary care patients[J]. Clin Infect Dis,2019,69(9):1517-1525.
[19] Ahmadi A, Ramazanzadeh R, Sayehmiri K, et al.Association of Chlamydia trachomatis infections with preterm delivery: A systematic review and meta-analysis[J].BMC Pregnancy Childbirth,2018,18(1):240.
[20] Rand LZ, Kesselheim AS.Controversy over using quality-adjusted life-years in cost-effectiveness analyses:A systematic literature review[J].Health Aff (Millwood), 2021, 40(9):1402-1410.
[21] Li Y, You S, Lee K, et al.The estimated lifetime quality-adjusted life-years lost due to chlamydia, gonorrhea, and trichomoniasis in the United States in 2018[J].J Infect Dis, 2023, 227(8):1007-1018.
[22] 李茜瑶,周莹,黄辉,等.疾病负担研究进展[J].中国公共卫生,2018,34(5): 777-780.
[23] 雷少元,郑荣寿,魏文强.伤残权重在恶性肿瘤疾病负担研究中的进展[J].中华肿瘤杂志,2021,43(7):756-761.
[24] Zheng Y, Yu Q, Lin Y, et al.Global burden and trends of sexually transmitted infections from 1990 to 2019:An observational trend study[J]. Lancet Infect Dis,2022,22(4):541-551.
[25] van Lier A, Mcdonald SA, Bouwknegt M, et al. Disease burden of 32 infectious diseases in the Netherlands,2007-2011[J].PLoS One,2016,11(4):e0153106.
[26] Sabbatucci M, Salfa MC, Regine V, et al.Estimated burden of chlamydia trachomatis female infection and consequent severe pelvic inflammatory disease, Italy,2005-2016[J].Ann Ist Super Sanita,2019,55(3):217-223.
[27] 杨晓雨,陈东宇,王红心,等.中国5种性传播感染的流行趋势[J].中国循证医学杂志, 2022, 22(7):778-784.
[28] 陈颖,龚巍巍.脑卒中经济负担研究方法及应用进展[J].预防医学,2019,31(6): 578-581,585.
[29] Owusu-Edusei K, Chesson HW, Gift TL, et al. The estimated direct medical cost of selected sexually transmitted infections in the United States,2008[J].Sex Transm Dis,2013,40(3): 197-201.
[30] Chesson HW, Spicknall IH, Bingham A, et al.The estimated direct lifetime medical costs of sexually transmitted infections acquired in the United States in 2018[J].Sex Transm Dis,2021,48(4):215-221.
[31] Zou Y, Liao Y, Liu F, et al.The annual economic burden of syphilis:An estimation of direct,productivity,and intangible costs for syphilis in Guangdong initiative for comprehensive control of syphilis sites[J].Sex Transm Dis,2017,44(11): 671-677.
[32] Kumar S, Chesson H, Gift TL.Estimating the direct medical costs and productivity loss of outpatient chlamydia and gonorrhea treatment[J].Sex Transm Dis,2021,48(2):e18-e21.
[33] Lee ASD, Cody SL.The stigma of sexually transmitted infections[J].Nurs Clin North Am,2020,55(3):295-305.
[34] Shui J, Xie D, Zhao J, et al.Seroepidemiology of chlamydia trachomatis Infection in the general population of Northern China: The Jidong Community Cohort Study[J].Front Microbiol,2021,12:729016.
[35] 胡跃华,李镒冲,刘世炜,等.中国20年间淋球菌,性传播衣原体,梅毒螺旋体的发病情况及其疾病负担[J].疾病监测,2015,30(11):904-910.
[36] GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:A systematic analysis for the Global Burden of Disease Study 2019BD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:A systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1204-1222.
[37] 中国疾病预防控制中心性病控制中心.关于印发《2022年全国性病防治工作要点》的通知[EB/OL].(2022-02-22)[2022-12-23].https://www.ncstdc.cn/#/home/ArticleDetails/u%3A6214481171f0a02a446b2441%23@a%3AXieshoue_Spread%23/STD_Official_Web_Home_Notice.

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	LIN Qiongfen, FAN Lirui, YU Ping, XU Huifang, YAO Zhilu, WANG Yatao, LIN Peng. Analysis of HIV testing willingness and its influencing factors among secondary vocational school students in Guangzhou [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1248-1252.
[2]	FAN Lirui, YAO Zhilu, WANG Yatao, LIANG Qinger, XU Huifang, LI Yan. Status and influencing factors of finding sexual partners through internet among secondary vocational school students in Guangzhou [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1253-1257.
[3]	CHEN Yuncong, YAO Zhilu, FAN Lirui, LIN Peng, LI Yan, YANG Fang, FU Xiaobing, JIANG Zini, WANG Yatao, HE Qi, CHEN Liuyan, XU Huifang. Evaluation of the impact of forum theatre on sexual health and HIV/AIDS prevention education among young students [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1258-1262.
[4]	JIANG Zini, XIE Shilan, XU Huifang, YAO Zhilu, HE Simin, WANG Yatao, LI Yan, LIN Peng, FU Xiaobing, GU Jing. Correlation between first sexual behavior and condom use in the past year among students in 10 technical and vocational schools in Guangdong Province [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1263-1267.
[5]	LI Jianrong, LI Yan, XU Huifang, PAN Siyuan, XIE Shilan, LIU Jun, JIE YU, JIANG Zini, YAO Zhilu, WANG Yatao, CHEN Liuyan, YANG Fang. Analysis of condom use and related factors among young students engaging in non-regular sexual partner behaviors in Guangdong Province [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1268-1272.
[6]	. [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1280-1284.
[7]	. [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1335-1338.
[8]	. [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1176-1179.
[9]	. [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1209-1212.
[10]	HU Longjun, XIE Haixia, HUANG Xiaowei, WU Shuyin, QIAN Mingping, LIN Peipei, WEI Yan, ZENG Xuheng, CHANG Fengshui. Daily life impact and its change of the COVID-19 on adult residents in some urban and rural areas in China in 2020-2021 [J]. South China Journal of Preventive Medicine, 2023, 49(8): 940-945.
[11]	MAI Jiemei, ZHONG Xiaoyan, XIAO Fengshan, CAI Xuelian, QIU Zhijian. Depression level and its influencing factors among medical workers in a district of Guangzhou [J]. South China Journal of Preventive Medicine, 2023, 49(8): 946-951.
[12]	. [J]. South China Journal of Preventive Medicine, 2023, 49(8): 1000-1004.
[13]	. [J]. South China Journal of Preventive Medicine, 2023, 49(8): 1045-1048.
[14]	. [J]. South China Journal of Preventive Medicine, 2023, 49(8): 1067-1070.
[15]	ZHANG Wei, FANG Lianghao, WEN Yunjing, LIAO Xinlong, QIN Pengzhe, ZHEN Ruonan, XU Jianxiong. Knowledge of mpox and the related factors among the Chinese [J]. South China Journal of Preventive Medicine, 2023, 49(7): 818-823.